DuPont is actively engaged in the global dialogue on nanotechnologies and biotechnologies. For example, the company has actively called for and engaged in collaboration in the development of responsible safety standards and test methods for new nanomaterials as well as the coordination of research to generate reliable, peer reviewed data and has called for the adoption of appropriate regulations. DuPont and Environmental Defense jointly developed, published and adopted the Nano Risk Framework, available at http://www.nanoriskframework.org, which is intended to be used as a process to identify, manage and reduce potential health, safety and environmental risks of nanoscale materials across all lifecycle stages. The company has also testified before the U.S. congress on the safety, health and environmental implications of new nanoscale technologies, and is an active participant in the Organization for Economic Co-operation and Development (OECD) Working Party on Health and Environmental Safety Implications of Manufactured Nanomaterials.
DuPont also is recognized as a global leader in the development of new
products using biotechnology. The company practices biotechnology with the
same commitment to safety that has marked more than 200 years of experience
in industrial safety. It complies with regulatory systems in each country
where its products are sold; supports rigorous testing and regulatory
safeguards that carefully consider both human health and environmental
protection; engages a panel of highly regarded outside experts who
regularly review its biotech programs (DuPon
Copyright©2008 PR Newswire.
All rights reserved